Cloning and Expression of Serratiopeptidase protein and assessment of its activity for clot lysis

Document Type : Research Paper

Authors

Department of Biology, College of Education for Pure Science, University of Anbar, Ramadi, Anbar, Iraq

Abstract

Objective
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide, with blood thrombosis playing a critical role in conditions such as myocardial infarction and stroke. Thrombolytic agents, including tissue plasminogen activators and streptokinase, are commonly used to dissolve blood clots and restore normal blood flow. However, these agents have several limitations, including high cost, short half-life, immune responses, and potential hemorrhagic complications, which restrict their widespread clinical use. Serratiopeptidase, a zinc-dependent metalloprotease produced by Serratia marcescens, has gained attention for its fibrinolytic, anti-inflammatory, and analgesic properties. This enzyme has demonstrated effective fibrin clot degradation with minimal side effects, making it a promising candidate for thrombolytic therapy. Additionally, its ability to bind to alpha-2-macroglobulin may help mask its antigenicity, potentially reducing immune-related adverse reactions. Despite these advantages, large-scale recombinant production of Serratiopeptidase is necessary to enhance its availability and therapeutic applications. In this study, we aimed to clone and express the Serratiopeptidase (STP) gene in Escherichia coli BL21(DE3) and evaluate the thrombolytic activity of the recombinant protein. Using molecular cloning techniques, followed by protein expression, purification, and fibrinolytic assays, we assessed the efficacy of recombinant Serratiopeptidase in clot degradation.
Materials and Methods
The STP gene was isolated from a pathogenic Serratia marcescens strain. The gene was digested with EcoR1, ligated into the expression vector pGEM®-3Zf, and transformed into E. coli BL21(DE3). Expression was induced using isopropyl β-D-1-thiogalactopyranoside (IPTG). The recombinant STP protein was analyzed via sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The fibrinolytic activity of the expressed Serratiopeptidase protein was assessed using blood clot lysis assays.
Results
The PCR product of the STP gene, approximately 1500 bp in size, was confirmed via agarose gel electrophoresis and sequencing. Successful cloning in E. coli was verified using 12% SDS-PAGE, which showed a protein band corresponding to the expected molecular weight of 52 kDa. Functional analysis demonstrated that the recombinant Serratiopeptidase effectively lysed human blood clots, showing complete clot degradation compared to the control.
Conclusion
Our findings indicate that recombinant Serratiopeptidase exhibits significant thrombolytic activity, effectively dissolving human blood clots. These results suggest that Serratiopeptidase could serve as a promising alternative to existing thrombolytic agents. Further studies are needed to optimize its production, assess its stability and safety, and explore its clinical applications for cardiovascular disease management.

Keywords


Alavi M, Mozafari MR, Ghaemi S, et al. (2022) Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study. Biomedicines 10 (12), e3074.
Amiri Roudbar M, Mohammadabadi MR, AyatollahiMehrgardi A, et al. (2020) Integration of single nucleotide variants and whole-genome DNA methylation profiles for classification of rheumatoid arthritis cases from controls. Heredity 124 (5), 658-674.
Araghi A, Hashemi S, Sepahi A, et al. (2019) Purification and study of anti-cancer effects of Serratiamarcescensserralysin. Iran J Microbiol 11(4), 320-327.
 Bhagat S, Agarwal M, Roy V (2013) Serratiopeptidase: a systematic review of the existing evidence. Int J Surg 11(3), 209-217.‏‏‏‏‏
Bick RL (1994) Disseminated intravascular coagulation: objective criteria for diagnosis and management. Med Clin North Am 78(3), 511-543.
Bordbar F, Mohammadabadi M, Jensen J, et al. (2022) Identification of candidate genes regulating carcass depth and hind leg circumference in simmental beef cattle using Illumina Bovine Beadchip and next-generation sequencing. Animals 12 (9), e1103.
Buniya HK, Murugan V, Thangadurai C (2014) Cloning and expression of hybrid streptokinase towards clot-specific activity. J Microbiol Methods 98, 84-88.
Buniya HK, HameedAK, Al-Hayawi AY (2023) Cloning and expression of staphylokinase-streptokinase recombinant protein in E. coli BL21(DE3). Biologia 78, 1113-1117.
Doshi P, Bhargava P, Singh V, et al. (2020) Escherichiacoli strain engineering for enhanced production of Serratiopeptidase for therapeutic applications. Int J Biol Macromol 160, 1050-1060.‏
Editor(s): William B. Coleman, Gregory J. Tsongalis, Essential Concepts in Molecular Pathology (Second Edition), Academic Press, 229-246.
Green MR, Sambrook J (2012) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York.
Grimont F, Grimont PAD (2006) The Genus Serratia. In: Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, KH., Stackebrandt, E. (eds) The Prokaryotes. Springer, New York, NY.
Grimont, P A D, and Grimont, F. (1978) The genus Serratia. Annu Rev Microbiol 32(1), 221-248.
Heidarpour F, Mohammadabadi MR, Zaidul ISM, et al. (2011) Use of prebiotics in oral delivery of bioactive compounds: a nanotechnology perspective. Pharmazie 66 (5), 319-324.
Hogan, S, Zapotoczna M, Stevens NT, et al. (2017) Potential use of targeted enzymatic agents in the treatment of Staphylococcusaureus biofilm-related infection. J Hosp Infect 96(2), 177-182. ‏
Iguchi, A, Nagaya Y, Pradel E, et al. (2014) Genome evolution and plasticity of Serratiamarcescens, an important multidrug-resistant nosocomial pathogen. Genome Biol Evol 6(8), 2096-2110.‏
Jadhav S B, Shah N, Rathi A, et al. (2020) Serratiopeptidase: Insights into the therapeutic applications. Biotechnol Rep 28, e00544.
 Jana S, Deb JK (2005) Strategies for efficient production of heterologousproteins in Escherichiacoli. Appl Microbiol Biotechnol 67(3), 289–298.
Kashash, RR, Abdul-Kareem IQ (2022) Molecular Identification of in Humans and Serratiamarcescens Birds in Baghdad Province, Iraq. Indian J Ecol 49(20), 502-508.
Khabiri A, Toroghi R, Mohammadabadi M, Tabatabaeizadeh SE (2023) Introduction of a Newcastle disease virus challenge strain (sub-genotype VII. 1.1) isolated in Iran. Vet Res Forum 14 (4), e221.
Kotb E (2013) Activity assessment of microbial fibrinolytic enzymes. Appl Microbiol Biotechnol 97(15), 6647-6665.
Kotb E (2014) The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi. Biotechnol Prog 30(3), 656-672. 
Krishnamurthy A, Belur PD (2018) A novel fibrinolytic serine metalloprotease from the marine Serratiamarcescens subsp. sakuensis: Purification and characterization. Int J Biol Macromol 112, 110-118.  
Levi M, Scully M (2018) How I treat disseminated intravascular coagulation. Blood 131(8), 845-854.
Mandel M, Higa A. (1970) Calcium-dependent bacteriophage DNA infection. J Mol Biol 53(1),159-162.
Martin K, Ma AD, Key NS (2020) Chapter 15 - Molecular basis of hemostatic and thrombotic diseases,
Mohammadabadi M, Babenko O, Borshch OO, et al. (2024) Measurement of the relative expression pattern of the UCP2 gene in different tissues of the Raini Cashmere goat. Agric Biotechnol J 16 (3), 317-332. 
Mohammadabadi M, Golkar A, Askari Hesni M (2023) The effect of fennel (Foeniculum vulgare) on insulin-like growth factor 1 gene expression in the rumen tissue of Kermani sheep. Agric Biotechnol J 15 (4), 239-256.
Mohammadabadi MR, AsadollahpourNanaei H (2021) Leptin gene expression in Raini Cashmere goat using Real Time PCR. Agric Biotechnol J 13 (1), 197-214
Mohankumar A, KrishnaRaj RH (2011) Production and Characterization of Serratiopeptidase Enzyme from Serratiamarcescens. Int J Biol 3(3), 39-51.
Mykhailenko A, Utevsky A, Solodiankin O, et al. (2020) First record of Serratiamarcescens from Adelie and Gentoo penguin faces collected in the Wilhelm Archipelago, Graham Land, West Antarctica. Polar Biol 43(7), 903-910.
Nair SR (2022) Serratiopeptidase: An integrated view of multifaceted therapeutic enzyme. Biomolecules 12(10), e1468
Natarajan K, Subashkumar R (2023) Synthesis and Characterization of Thrombolytic Serratiopeptidase from Environmental Isolates of Serratiamarcescens. Res J Pharm Technol 16(10), 4698-4702.
Procop GW, Church DL, Hall GS, et al. (2017) Koneman's Color Atlas and Textbook of Diagnostic. 7th ed. Philadelphia: Wolters Kluwer, 845-853.
Santhosh K (2018) The emerging role of Serratiopeptidase in oral surgery: literature update. Asian J Clin Pharm Res 11(3), 19-23.
Shahsavari M, Mohammadabadi M, Khezri A, et al. (2023) Correlation between insulin-like growth factor 1 gene expression and fennel (Foeniculum vulgare) seed powder consumption in muscle of sheep. Anim Biotechnol 34 (4), 882-892.
Shrivastava S, Shukla P, Deepalakshmi PD, Mukhopadhyay K (2013) Mukhopadhyay, Characterization, cloning and functional expression of novel xylanase from Thermomyceslanuginosus SS-8 isolated from self-heating plant wreckage material. World J Microbiol Biotechnol 12, 2407–2415.
Sole M, Francia A, Rius N, Loren JG (1994) The role of pH in the glucose effect‖ on prodigiosin production by non-proliferating cells of Serratiamarcescens. Lett Appl Microbiol 19(5), 341-344.
Srivastava V, Mishra S, Chaudhuri T K (2019) Enhanced production of recombinant Serratiopeptidase in Escherichiacoli and its characterization as a potential biosimilar to native biotherapeutic counterpart. Microb Cell Fact 18, e215.
Tiwari M (2017) The role of Serratiopeptidase in the resolution of inflammation. Asian J Pharm Sci 12(3), 209-215. 
Tough J (2005) Thrombolytic therapy in acute myocardial infarction. Nurs Stand 19(37), 55-64.
Zhao D (2021) Epidemiological features of cardiovascular disease in Asia. JACC Asia 1(1), 1-13.
Zivkovic Zaric R, Zaric M, Sekulic M, et al. (2023) Antimicrobial treatment of Serratiamarcescensinvasive infections: systematic review. Antibiotics 12(2), e367.